Dengvaxia first dengue vaccine approved in Brazil
With 1.4 million dengue cases reported this year, Brazil stands to gain tremendous value from this new dengue prevention tool…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sanofi
Dengue vaccine Dengvaxia approved in Mexico
First marketing authorization of Dengvaxia is a historic milestone paving the way to significantly impact dengue burden in endemic…
Sanofi teams up with Evotec, Apeiron
To develop immuno-oncology pills
Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to…
Sanofi appoints Suresh Kumar to Executive Committee
He will take the position as Executive Vice President and External Affairs
Sanofi appointed Suresh Kumar as a new member of the…
Big Pharma drives innovation in pain therapy development, despite declining patent applications
Patent applications for pain treatments between 2008 and 2012 were dominated by Big Pharma, including Sanofi, Novartis and Merck…
Genzyme’s Lemtrada approved by the FDA
First approved in September 2013 in the European Union
Sanofi Pasteur launches paediatric pentavalent vaccine in India
The launch of Shan5 vaccine receives pre-qualification status from the World Health Organization